TSZY(002872)

Search documents
证监会连开亿元罚单,多家上市公司涉财务造假遭重罚
Xin Lang Cai Jing· 2025-09-14 13:09
Core Viewpoint - The China Securities Regulatory Commission (CSRC) has intensified its crackdown on financial fraud among listed companies, imposing significant penalties on multiple firms for financial misconduct, with some companies facing penalties exceeding 100 million yuan [1] Group 1: Regulatory Actions - On September 12, several companies including *ST Dongtong (300379.SZ), Lieneng 5 (formerly Yili Clean Energy), *ST Guangdao (839680.BJ), ST Tiansheng (002872.SZ), *ST Xinchao (600777.SH), and *ST Lingda (300125.SZ) disclosed administrative penalties from the CSRC [1] - Companies such as *ST Dongtong and Lieneng 5, along with their executives, were fined over 100 million yuan [1] Group 2: Industry Trends - The regulatory environment has shifted towards a "zero tolerance" approach regarding financial fraud, with enforcement actions becoming increasingly stringent [1] - This year, numerous companies have received penalties exceeding 100 million yuan due to significant financial fraud, with over ten companies facing forced delisting as a result of major violations [1] - Even companies that have already been delisted continue to face accountability for their financial misconduct [1]
晚间公告丨9月14日这些公告有看头
Di Yi Cai Jing· 2025-09-14 10:36
Key Points - The article summarizes important announcements from various companies for investor reference [1] Group 1: Stock Performance and Trading - Jushen Co., Ltd. (炬申股份) experienced a stock price fluctuation with a cumulative increase of over 20% from September 10 to September 12, 2025, and is consistent with its previously disclosed share reduction plan [3] - ST Zitian (*ST紫天) will resume trading on September 15, 2025, and enter a delisting arrangement period lasting 15 trading days, with the last trading date expected to be October 13, 2025 [5] Group 2: Mergers and Acquisitions - Huibo Yuntong (慧博云通) announced that its controlling shareholder plans to acquire a total of 32.0875% of Baode Computing's shares for a total transaction price of 1.444 billion yuan, which will grant control over Baode Computing [4] Group 3: Shareholder Actions - Jifa Education (佳发教育) announced that its shareholder, De Yuan Tai, plans to reduce its stake by up to 3%, equating to 11.9854 million shares [9] - Da Yi Long (达意隆) disclosed that its shareholder, Shenzhen Lefeng Investment Management Co., Ltd., intends to reduce its stake by up to 3%, or 5.9708 million shares [10] - Multiple companies, including Pruis (普蕊斯), Wanda Information (万达信息), and Jianlong Micro-Nano (建龙微纳), reported plans for shareholders to reduce their stakes by up to 3% [11][13][14] Group 4: Operational Updates - Yongyue Technology (永悦科技) announced that its actual controller, Chen Xiang, has been released on bail pending trial due to an investigation related to information disclosure [6] - ST Tiansheng (ST天圣) received approval for its sodium bicarbonate injection to pass the consistency evaluation for generic drugs, which is used in clinical treatments [7] Group 5: Performance Metrics - Shanghai Airport (上海机场) reported that in August 2025, Pudong International Airport had a passenger throughput of 7.9471 million, a year-on-year increase of 6.9%, while Hongqiao International Airport had 4.4515 million, a 2.18% increase [20] Group 6: Contract Awards - Dashi Intelligent (达实智能) signed a contract worth 23.869 million yuan for the Xiaomi Wuhan Phase II intelligent project, which represents 0.75% of the company's audited revenue for 2024 [22]
ST天圣(002872.SZ):湖北天圣产品碳酸氢钠注射液通过仿制药一致性评价
Ge Long Hui A P P· 2025-09-14 08:41
Core Viewpoint - ST Tian Sheng (002872.SZ) announced that its wholly-owned subsidiary, Hubei Tian Sheng Pharmaceutical Co., Ltd., has received the approval notice from the National Medical Products Administration for its product "Sodium Bicarbonate Injection," which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The approval of "Sodium Bicarbonate Injection" indicates a significant milestone for the company in the pharmaceutical sector [1] - The consistency evaluation is crucial for generic drugs, ensuring they meet the same quality and efficacy standards as their branded counterparts [1]
ST天圣(002872) - 关于全资子公司碳酸氢钠注射液通过仿制药一致性评价的公告
2025-09-14 07:45
一、药品基本情况 二、药品其他相关情况 证券代码:002872 证券简称:ST 天圣 公告编号:2025-056 天圣制药集团股份有限公司 关于全资子公司碳酸氢钠注射液通过仿制药 一致性评价的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 天圣制药集团股份有限公司(以下简称"公司")之全资子公司湖北天圣药 业有限公司(以下简称"湖北天圣")于近日收到国家药品监督管理局核准签发 的《药品补充申请批准通知书》,湖北天圣产品"碳酸氢钠注射液"通过仿制药 质量与疗效一致性评价(以下简称"一致性评价")。现就相关事项公告如下: | 药品通用名称 | 碳酸氢钠注射液 | | | | --- | --- | --- | --- | | 剂型 | | 注射剂 注册分类 | 化学药品 | | 规格 | | 10ml:0.42g 原药品批准文号 | 国药准字 H42020420 | | 包装规格 | | 药品注册标准编号 5 支/盒 | YBH23982025 | | 申请内容 | | 新增申报规格 10ml:0.42g,同时申请仿制药质量和疗效一致性评 | | | | | ...
ST天圣:碳酸氢钠注射液通过仿制药一致性评价
Zheng Quan Shi Bao Wang· 2025-09-14 07:44
Core Viewpoint - ST Tian Sheng's subsidiary, Hubei Tian Sheng, has received approval from the National Medical Products Administration for its sodium bicarbonate injection, which has passed the consistency evaluation for generic drug quality and efficacy [1] Company Summary - The sodium bicarbonate injection is primarily used in clinical settings for the treatment of metabolic acidosis, alkalinizing urine, and as a non-specific treatment for certain drug overdoses through intravenous infusion [1]
ST天圣财务造假实锤!22人被罚,实控人终身禁入
Shen Zhen Shang Bao· 2025-09-13 12:58
Core Viewpoint - ST Tian Sheng has been penalized by the China Securities Regulatory Commission (CSRC) for inflating profits and failing to disclose related party transactions, resulting in a total fine of 4.99 million yuan [1][4]. Group 1: Financial Misconduct - ST Tian Sheng inflated its total profit by 92,204,254.47 yuan in 2017 and 28,823,001.51 yuan in 2018, which accounted for 30.21% and 20.61% of the reported profits for those years respectively [2]. - The company used off-balance sheet funds to pay sales expenses, leading to inflated profits of 174,783,429.59 yuan in 2017 and 47,908,869.95 yuan in 2018 [2]. - Additionally, ST Tian Sheng understated its profits by 82,579,175.12 yuan in 2017 and 19,085,868.44 yuan in 2018 through inflated procurement costs [2]. Group 2: Disclosure Failures - In 2017 and 2018, ST Tian Sheng failed to disclose related party transactions amounting to 481,025,946.65 yuan and 48,631,061.00 yuan, which represented 15.08% and 1.49% of the net assets at the end of those periods [3]. - The undisclosed related party transactions included 328,521,817.60 yuan that exceeded 15% of the latest audited net assets, violating disclosure regulations [3]. Group 3: Regulatory Actions - The CSRC has issued a warning and imposed a fine of 60,000 yuan for the failure to disclose related party transactions and for the false records in the annual reports [4]. - The former chairman Liu Qun has been fined 90,000 yuan and banned from the market for life due to his role in directing these illegal activities [4]. - Following these actions, ST Tian Sheng's stock will be subject to additional risk warnings, maintaining its designation as "ST Tian Sheng" with a trading code of 002872 [4].
ST天圣(002872.SZ):公司股票交易被叠加实施其他风险警示

Ge Long Hui A P P· 2025-09-12 14:15
Group 1 - The company ST Tian Sheng (002872.SZ) received an administrative penalty notice from the China Securities Regulatory Commission on September 12, 2025, indicating that the financial indicators in its annual report contained false records [1] - The notice states that the company violated Article 9.8.1, Item 8 of the Shenzhen Stock Exchange Listing Rules, which will result in additional risk warnings for its stock [1] - Following the additional risk warning, the stock will continue to be traded under the name "ST Tian Sheng" with the same stock code 002872, and the daily price fluctuation limit remains at 5% [1]
ST天圣:公司股票交易被叠加实施其他风险警示
Ge Long Hui· 2025-09-12 13:55
格隆汇9月12日丨ST天圣(002872.SZ)公布,公司于2025年9月12日收到中国证券监督管理委员会重庆监 管局出具的《行政处罚事先告知书》,根据本次《行政处罚事先告知书》认定的情况,公司披露的年度 报告财务指标存在虚假记载,触及《深圳证券交易所股票上市规则》第9.8.1条第八项的情形,公司股票 将被叠加实施其他风险警示。本次被叠加实施其他风险警示后,股票简称仍为"ST天圣",股票代码仍 为002872,股票交易的日涨跌幅限制仍为5%。本次叠加其他风险警示,公司股票不停牌。 ...
重庆证监局严处ST天圣信披违法
Zhong Zheng Wang· 2025-09-12 13:37
中证报中证网讯(记者 吴科任)9月12日晚,ST天圣(002872)发布公告称,公司收到重庆证监局行政 处罚事先告知书。这起信息披露违法案件系ST天圣实控人刘群刑事犯罪行为的伴生案件,再次释放出 资本市场"零容忍"监管的明确信号,更为维护投资者合法权益、筑牢市场诚信根基写下生动注脚。 值得关注的是,本案的查处体现了"立体追责"的监管智慧。在司法机关已对刘群以侵占、挪用上市公司 资金罪判处19年有期徒刑的基础上,重庆证监局迅速跟进启动行政调查,及时对信披违法行为作出认定 处罚;同时明确将对相关第三方机构进行查处,从严打击"帮凶"行为,形成刑事、行政追责的闭环。更 关键的是,在处罚决定生效后,监管部门还将积极协调中证中小投资者服务中心与成渝金融法院,推动 适格投资者通过代表人诉讼等机制主张民事赔偿。 回溯案件,ST天圣在2017年和2018年通过账外资金池支付销售费用等方式,分别虚增利润总额0.92亿元 和0.28亿元,分别对应占当期披露利润的30.21%和20.61%。重庆证监局依据《证券法》,对ST天圣及 22名责任人员合计处以439万元罚款,更对刘群采取终身市场禁入措施,对2名相关责任人分别实施5 年、8年 ...
ST天圣(002872) - 2025年第三次临时股东大会决议公告
2025-09-12 13:30
证券代码:002872 证券简称:ST 天圣 公告编号:2025-055 天圣制药集团股份有限公司 2025 年第三次临时股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有 虚假记载、误导性陈述或重大遗漏。 特别提示: 1、本次股东大会未出现否决议案的情形; 2、本次股东大会不涉及变更以往股东大会决议的情形。 一、会议召开的基本情况 1、会议召开时间 (1)现场会议时间:2025 年 9 月 12 日(星期五)下午 14:00 开始。 1 参加本次股东大会现场会议和网络投票的股东(包括股东代理人)共计 100 名,代表有表决权的股份数量 113,225,082 股,占公司有表决权股份总数的 35.6054%。其中: (1)出席现场会议的股东(包括股东代理人)共 6 名,代表有表决权的股 份为 105,331,411 股,占公司有表决权股份总数的 33.1231%。 (2)网络投票时间:其中,通过深圳证券交易所交易系统进行网络投票的 具体时间为:2025 年 9 月 12 日 9:15-9:25,9:30-11:30 和 13:00-15:00;通过深圳 证券交易所互联网投票系统投 ...